Skip to main content

Shanmugam Muthusamy's Form 4 filing

Ani Pharmaceuticals Inc (ANIP) · filed Jul 17, 2024

Accession no.
0001870913-24-000026
Filed
Jul 17, 2024
Trade date
Jul 15-17, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions. Open-market sales total $3.01M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Shanmugam MuthusamyCIK 0001870913Director, Officer (HEAD OF R&D, COO-NOVITIUM OPS)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 15, 2024Common StockSSaleDisposed−11,000$63.38F2−$697,180671,620Indirect
Jul 16, 2024Common StockSSaleDisposed−22,000$64.27F4−$1,413,940649,620Indirect
Jul 17, 2024Common StockSSaleDisposed−14,257$63.16F5−$900,472.12635,363Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The shares were sold in multiple trades at prices ranging from $62.47 to $64.19. The price reported above reflects the weighted average sales price.

Referenced by the price of 1 transaction in Table I.

F4

The shares were sold in multiple trades at prices ranging from $63.25 to $64.91. The price reported above reflects the weighted average sales price.

Referenced by the price of 1 transaction in Table I.

F5

The shares were sold in multiple trades at prices ranging from $62.62 to $64.21. The price reported above reflects the weighted average sales price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)